Print

IAVI V001

A Phase I, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of a Multiclade HIV-1 DNA Plasmid Vaccine Followed by recombinant, Multiclade HIV-1 Adenoviral Vector Vaccine or the Multiclade HIV-1 Adenoviral Vector Vaccine Alone in Healthy Adult Volunteers not Infected with HIV

Trial Details:

I Completed
International AIDS Vaccine Initiative (IAVI), National Institute of Allergy and Infectious Diseases (NIAID), Vaccine Research Center (VRC) November 01, 2005
VRC-HIVDNA016-00-VP,VRC-HIVADV014-00-VP DNA env A, env b, env C, gag B, pol B, nef B; Ad5 env A, env B, env C, gag B, pol B
VRC-HIVDNA016-00-VP DNA
VRC-HIVADV014-00-VP Viral Vector - Adeno
Kenya, Rwanda 114
NCT00124007
http://www.clinicaltrials.gov/ct/show/NCT00124007?order=1